Correction to: Translational Psychiatry (2017) 7, e1056; doi:10.1038/tp.2017.10; published online 14 March 2017
The ninth author’s affiliation was presented incorrectly in the published paper. Additionally, only the first affiliation should have included CHU Hôpital Le Cluzeau. The correct affiliations appear below:
E Lemonnier1, N Villeneuve2, S Sonie3, S Serret4, A Rosier5, M Roue6, P Brosset1, M Viellard2, D Bernoux7, S Rondeau5, S Thummler4, D Ravel8 and Y Ben-Ari8,9
1CHU Hôpital Le Cluzeau, CHU Limoges, Limoges, France
2Hôpital Sainte Marguerite, Marseille, France
3CHU le Vinatier, Bron, France
4CHU Lenval, Nice, France
5CHU Le Rouvray, Sotteville les Rouen, France
6CHRU Brest, Brest, France
7EPICIME-CIC 1407 de Lyon, Hospices Civils de Lyon, Inserm, Bron, France
8Neurochlore Research Team, Marseille, France
9Neurochlore Research Team, C/O INMED, INSERM Unité 901, Aix Marseille Université, Marseille, France
Additional information
The online version of the original article can be found at 10.1038/tp.2017.10
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Lemonnier, E., Villeneuve, N., Sonie, S. et al. Erratum: Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. Transl Psychiatry 7, e1124 (2017). https://doi.org/10.1038/tp.2017.101
Published:
Issue Date:
DOI: https://doi.org/10.1038/tp.2017.101
This article is cited by
-
Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial
Journal of Autism and Developmental Disorders (2024)
-
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Molecular Autism (2022)
-
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
Molecular Autism (2020)
-
Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth
Scientific Reports (2019)
-
Developmental Phenotype of the Rare Case of DJ Caused by a Unique ADNP Gene De Novo Mutation
Journal of Molecular Neuroscience (2019)
